Cargando…

Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial

BACKGROUND: Self-administered medication (SAM) is encouraged in many hospitals worldwide as it increases patients’ knowledge and understanding of their medication, but the effects on other outcomes, e.g. compliance or medication errors, were unclear. OBJECTIVES: To compare medication knowledge, adhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaday, Ronee, Ratanajamit, Chaveewan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194043/
https://www.ncbi.nlm.nih.gov/pubmed/32377277
http://dx.doi.org/10.18549/PharmPract.2020.2.1766
_version_ 1783528289511407616
author Kaday, Ronee
Ratanajamit, Chaveewan
author_facet Kaday, Ronee
Ratanajamit, Chaveewan
author_sort Kaday, Ronee
collection PubMed
description BACKGROUND: Self-administered medication (SAM) is encouraged in many hospitals worldwide as it increases patients’ knowledge and understanding of their medication, but the effects on other outcomes, e.g. compliance or medication errors, were unclear. OBJECTIVES: To compare medication knowledge, adherence, medication errors, and hospital readmission among inpatients receiving SAM education under the supervision of a multidisciplinary team (study group) with those receiving routine nurse-administered medication (control group). METHODS: This study was a PROBE design. Inpatients with chronic diseases were randomly allocated (1:1) to either the study group or the control group using stratified-block randomization. Knowledge of medications was measured at hospital discharge and at the first two follow-up visits; adherence was measured at the first two follow-up visits, medication errors while in hospital, and hospital readmission within 60 days after discharge. For normally distributed continuous outcomes, mean difference and 95%CI were estimated; otherwise the median and the Mann-Whitney test p-value were reported. The percentage difference and 95%CI were reported for binary outcomes. RESULTS: 70 patients were randomized (35 in each group); all received complete follow-up. Both groups were similar at baseline. Mean (SD) age (years) were 59.2 (11.0) for the study group and 58.3 (12.0) for the control group. Percentages of females in the respective groups were 54.3 and 60.0. Mean time from discharge to the first follow-up visit was two weeks in both groups and time to the second follow-up visit were 68.8 days (study group) and 55.0 days (control group). The study group had significantly higher medication knowledge than the control group at hospital discharge (of the 10-point scale, medians, 8.56 and 6.18, respectively, p<0.001). The corresponding figures were similar in both groups at the first follow-up visit (medians, 8.25 and 6.26, respectively, p<0.001). Adherence to medication at the first visit in the study group (percentage mean 92.50% (SD=5.33%)) was significantly higher than that in the control group (79.60% (SD=5.96%)), percentage mean difference 12.90%, [95%CI 10.20%:15.60%], p<0.001. Medication knowledge and adherence were sustained at the second follow-up visit. During hospitalization, no medication errors were found in the study group, and minimal errors occurred in the control group (1.48%, [95%CI 0.68%:2.28%] of doses administered, p=0.001). Hospital readmission within 60 days after discharge was significantly lower in the study group (11.4%) than that in the control group (31.4%), percentage difference 20.0% (95%CI 1.4%:38.6%), 1-side Fisher exact p=0.039. CONCLUSIONS: Among in-patients with chronic diseases, SAM program significantly increased knowledge of and adherence to prescribed medications. Medication errors regarding administration errors were infrequent but significantly higher in the control group. SAM reduced hospital readmission within 60 after discharge.
format Online
Article
Text
id pubmed-7194043
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-71940432020-05-06 Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial Kaday, Ronee Ratanajamit, Chaveewan Pharm Pract (Granada) Original Research BACKGROUND: Self-administered medication (SAM) is encouraged in many hospitals worldwide as it increases patients’ knowledge and understanding of their medication, but the effects on other outcomes, e.g. compliance or medication errors, were unclear. OBJECTIVES: To compare medication knowledge, adherence, medication errors, and hospital readmission among inpatients receiving SAM education under the supervision of a multidisciplinary team (study group) with those receiving routine nurse-administered medication (control group). METHODS: This study was a PROBE design. Inpatients with chronic diseases were randomly allocated (1:1) to either the study group or the control group using stratified-block randomization. Knowledge of medications was measured at hospital discharge and at the first two follow-up visits; adherence was measured at the first two follow-up visits, medication errors while in hospital, and hospital readmission within 60 days after discharge. For normally distributed continuous outcomes, mean difference and 95%CI were estimated; otherwise the median and the Mann-Whitney test p-value were reported. The percentage difference and 95%CI were reported for binary outcomes. RESULTS: 70 patients were randomized (35 in each group); all received complete follow-up. Both groups were similar at baseline. Mean (SD) age (years) were 59.2 (11.0) for the study group and 58.3 (12.0) for the control group. Percentages of females in the respective groups were 54.3 and 60.0. Mean time from discharge to the first follow-up visit was two weeks in both groups and time to the second follow-up visit were 68.8 days (study group) and 55.0 days (control group). The study group had significantly higher medication knowledge than the control group at hospital discharge (of the 10-point scale, medians, 8.56 and 6.18, respectively, p<0.001). The corresponding figures were similar in both groups at the first follow-up visit (medians, 8.25 and 6.26, respectively, p<0.001). Adherence to medication at the first visit in the study group (percentage mean 92.50% (SD=5.33%)) was significantly higher than that in the control group (79.60% (SD=5.96%)), percentage mean difference 12.90%, [95%CI 10.20%:15.60%], p<0.001. Medication knowledge and adherence were sustained at the second follow-up visit. During hospitalization, no medication errors were found in the study group, and minimal errors occurred in the control group (1.48%, [95%CI 0.68%:2.28%] of doses administered, p=0.001). Hospital readmission within 60 days after discharge was significantly lower in the study group (11.4%) than that in the control group (31.4%), percentage difference 20.0% (95%CI 1.4%:38.6%), 1-side Fisher exact p=0.039. CONCLUSIONS: Among in-patients with chronic diseases, SAM program significantly increased knowledge of and adherence to prescribed medications. Medication errors regarding administration errors were infrequent but significantly higher in the control group. SAM reduced hospital readmission within 60 after discharge. Centro de Investigaciones y Publicaciones Farmaceuticas 2020 2020-04-19 /pmc/articles/PMC7194043/ /pubmed/32377277 http://dx.doi.org/10.18549/PharmPract.2020.2.1766 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Kaday, Ronee
Ratanajamit, Chaveewan
Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial
title Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial
title_full Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial
title_fullStr Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial
title_full_unstemmed Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial
title_short Inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial
title_sort inpatient self-administered medication under the supervision of a multidisciplinary team: a randomized, controlled, blinded parallel trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194043/
https://www.ncbi.nlm.nih.gov/pubmed/32377277
http://dx.doi.org/10.18549/PharmPract.2020.2.1766
work_keys_str_mv AT kadayronee inpatientselfadministeredmedicationunderthesupervisionofamultidisciplinaryteamarandomizedcontrolledblindedparalleltrial
AT ratanajamitchaveewan inpatientselfadministeredmedicationunderthesupervisionofamultidisciplinaryteamarandomizedcontrolledblindedparalleltrial